“Cytotoxic effect of imatinib on the normal myeloid and cancer cells of patients with chronic myelogenous leukemia”, Iraqi j. cancer med. genet., vol. 9, no. 1, Jun. 2016, doi: 10.29409/ijcmg.v9i1.181.